Loading...
Sitagliptin
India Pharmaceutical Trade Intelligence
Who Supplies Sitagliptin to India from CANADA
India's sitagliptin imports from CANADA total $43.8K across 50 shipments from 14 foreign suppliers. APOTEX INC leads with $26.8K in import value; the top 5 suppliers together control 92.7% of this origin. Leading Indian buyers include APOTEX RESEARCH PRIVATE LIMITED. This corridor reflects India's pharmaceutical import demand for sitagliptin — a diversified sourcing base with multiple active suppliers from CANADA.
Top foreign suppliers (CANADA) — Ranked by import value
APOTEX INC is the leading Sitagliptin supplier from CANADA to India, with import value of $26.8K across 10 shipments. The top 5 suppliers — APOTEX INC, SAVI CLINICALS FZ LLC, GLOBYZ PHARMA, M/S AURO PHARMA INC.,CANADA, AURO PHARMA INC., CANADA — collectively account for 92.7% of total import value from this origin.
Top foreign suppliers (CANADA)
Ranked by import value (USD) · Indian Customs (DGFT) data
| # | Supplier | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | APOTEX INC | $26.8K | 10 | 61.2% |
| 2 | SAVI CLINICALS FZ LLC | $7.5K | 3 | 17.1% |
| 3 | GLOBYZ PHARMA | $2.4K | 11 | 5.5% |
| 4 | M/S AURO PHARMA INC.,CANADA | $2.3K | 2 | 5.2% |
| 5 | AURO PHARMA INC., CANADA | $1.6K | 3 | 3.6% |
| 6 | LABORATOIRE RIVA INC | $1.4K | 3 | 3.2% |
| 7 | M/S. LABORATOIRE RIVA INC | $474 | 2 | 1.1% |
| 8 | Delpharm Montreal Inc | $430 | 1 | 1.0% |
| 9 | GLOBYZ PHARMA. | $362 | 3 | 0.8% |
| 10 | M/S. PHARMARIS CANADA INC. | $159 | 1 | 0.4% |
| 11 | LABORATORIE RIVA INC. | $126 | 4 | 0.3% |
| 12 | PHARMARIS CANADA INC | $102 | 1 | 0.2% |
| 13 | Delpharm Montreal Inc. | $97 | 4 | 0.2% |
| 14 | ACCEL PHARMA | $16 | 2 | 0.0% |
Showing top 14 of 14 foreign suppliers · Indian Customs (DGFT) · TransData Nexus
Top Indian buyers (importing from CANADA)
Ranked by import value (USD)
| # | Buyer | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | APOTEX RESEARCH PRIVATE LIMITED | $26.8K | 10 | 61.2% |
| 2 | MSN LABORATORIES PRIVATE LIMITED | $7.5K | 3 | 17.1% |
| 3 | AUROBINDO PHARMA LTD | $3.9K | 5 | 8.9% |
| 4 | JAMP INDIA PHARMACEUTICALS PRIVATE LIMITED | $1.8K | 8 | 4.1% |
| 5 | FINOSO PHARMA PRIVATE LIMITED | $1.5K | 7 | 3.5% |
| 6 | LAURUS LABS LIMITED | $653 | 3 | 1.5% |
| 7 | JEEVAN SCIENTIFIC TECHNOLOGY LIMITED | $474 | 2 | 1.1% |
| 8 | AZURITY PHARMACEUTICALS INDIA LLP | $430 | 1 | 1.0% |
| 9 | UNICHEM LABORATORIES LIMITED | $362 | 3 | 0.8% |
| 10 | VEEDA CLINICAL RESEARCH LIMITED | $261 | 2 | 0.6% |
| 11 | SLAYBACK PHARMA INDIA LLP | $97 | 4 | 0.2% |
| 12 | LYRUS LIFE SCIENCES PRIVATE LIMITED | $16 | 2 | 0.0% |
Import Statistics
- Import Value
- $43.8K
- Shipments
- 50
- Foreign Suppliers
- 14
- Indian Buyers
- 12
- Avg. Shipment
- $875
Other Sitagliptin Import Origins
Related Analysis
Frequently Asked Questions — Sitagliptin Imports from CANADA
Answers based on Indian Customs (DGFT) import records compiled by TransData Nexus
QWho are the top Sitagliptin suppliers from CANADA to India?
The top Sitagliptin suppliers from CANADA to India include APOTEX INC, SAVI CLINICALS FZ LLC, GLOBYZ PHARMA. The leading supplier is APOTEX INC with import value of $26.8K USD across 10 shipments. India imported Sitagliptin worth $43.8K USD from CANADA in total across 50 shipments.
QHow much Sitagliptin does India import from CANADA?
India imported Sitagliptin worth $43.8K USD from CANADA across 50 shipments. Data is from Indian Customs (DGFT) records. Values are in USD.
QWho are the main Indian buyers of Sitagliptin from CANADA?
The main Indian buyers of Sitagliptin sourced from CANADA include APOTEX RESEARCH PRIVATE LIMITED, MSN LABORATORIES PRIVATE LIMITED, AUROBINDO PHARMA LTD. The largest buyer is APOTEX RESEARCH PRIVATE LIMITED with $26.8K in imports across 10 shipments.
QWhat is the total value of Sitagliptin imports from CANADA to India?
The total value of Sitagliptin imports from CANADA to India is $43.8K USD, across 50 shipments and 14 foreign suppliers. Data source: Indian Customs (DGFT).
Official References & Regulatory Resources
- India Trade Statistics (DGFT)
- Invest India — Pharma Sector
- WCO HS Nomenclature
- Ministry of Commerce — Pharma Exports
- Pharmexcil
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Research Methodology & Data Transparency
SS
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Route Identification: CANADA to India pharmaceutical import trade corridor identified from Indian Customs (DGFT) shipping bill records for Sitagliptin.
- 2.Supplier/Buyer Matching: 14 foreign suppliers from CANADA and 12 Indian buyers identified using company name normalization across customs records.
- 3.Value Aggregation: Total import value of $43.8K aggregated from 50 verified shipping bill records. All values reported in FOB USD as recorded by Indian Customs.
- 4.Market Share Analysis: Each supplier and buyer contribution calculated as a percentage of total route value. Statistical normalization applied to ensure accurate representation across varying shipment sizes.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
50 Verified Shipments
14 suppliers, 12 buyers tracked
Expert-Reviewed
By pharmaceutical trade specialists